%PDF-1.4
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2018-04-25T15:59:28+05:30
2018-04-25T15:59:28+05:30
2018-04-25T15:59:28+05:30
Adobe InDesign CS6 (Macintosh)
uuid:311bf595-aa21-4243-84b8-620cf5ffa9dd
xmp.did:01801174072068118DBB881A9EDFAAFA
xmp.id:A8F8C28121206811822ACC29E75E6A85
proof:pdf
converted
from application/x-indesign to application/pdf
Adobe InDesign CS6 (Macintosh)
/
2018-04-25T15:59:28+05:30
xmp.iid:A6F8C28121206811822ACC29E75E6A85
xmp.did:01801174072068118DBB881A9EDFAAFA
xmp.did:01801174072068118DBB881A9EDFAAFA
default
application/pdf
Adobe PDF Library 10.0.1
False
endstream
endobj
5 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[9.0 9.0 621.0 801.0]/Type/Page>>
endobj
8 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[9.0 9.0 621.0 801.0]/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[9.0 9.0 621.0 801.0]/Type/Page>>
endobj
29 0 obj
<>stream
q
/GS0 gs
/Fm0 Do
Q
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
11 0 0 11 45 51.6404 Tm
(50)Tj
ET
q
0 g
/GS0 gs
/Fm1 Do
Q
0 0 0 1 K
q 1 0 0 1 45 705.5 cm
0 0 m
258 0 l
S
Q
q 1 0 0 1 45 537.5 cm
0 0 m
258 0 l
S
Q
BT
/C2_0 1 Tf
-0.03 Tc 0.03 Tw 10.25 0 0 10.25 45 687 Tm
<002400550057004C0046004F004800030046004C005700440057004C00520051001D>Tj
/TT0 1 Tf
0 Tc 0 Tw 10.5 0 0 10.5 114.3803 687 Tm
( )Tj
/C2_1 1 Tf
0.248 0 Td
<002C005A0058004D004C0003002E000F00030025004C004D004F00440051004C00030036000F0003002C005D00580046004B004C00030035000F00030036005200570048004F004F00520003002700110003>Tj
-6.855 -1.19 Td
<0024005800570052004C0050005000580051004C0057005C0003004C005100030046005C00560057004C0046000300BF0045005500520056004C0056001D00030056004C004A0051004C00BF00460044005100460048000300440051004700030046004F004C0051004C00460044004F0003>Tj
0 -1.19 TD
[<004C00500053004F004C004600440057004C00520051005600110003>17.3<0037004B004800030036005200580057004B005A00480056005700030035004800560053004C00550044005700520055005C0003004400510047000300260055004C0057004C00460044004F0003>]TJ
0 -1.19 TD
[<002600440055004800030026004B005500520051004C0046004F0048005600110003001500130014001B001E0019000B00150016000C001D>13.1<0017>14.9<001B>14.9<00B1>14.8<0018>14.8<0013>]TJ
/C2_0 1 Tf
10.25 0 0 10.25 45 637 Tm
<0029005500520050001D>Tj
/C2_1 1 Tf
10.5 0 0 10.5 74.0383 637 Tm
[<000300270048005300440055005700500048005100570003005200490003002C005100570048005500510044004F0003003000480047004C0046004C005100480003004400570003>17.1<0037>111<0048005B004400560003>17.9<0037>111<00480046004B0003>]TJ
-2.766 -1.19 Td
[<00380051004C0059004800550056004C0057005C0003002B00480044004F0057004B000300360046004C004800510046004800560003002600480051005700480055>53.3<000F0003002F00580045004500520046004E000F0003>18<0037003B>]TJ
/C2_0 1 Tf
10.25 0 0 10.25 45 612 Tm
<0036005800450050004C0057005700480047001D>Tj
/TT0 1 Tf
10.5 0 0 10.5 98.5222 612 Tm
( 2/14/2018)Tj
/C2_0 1 Tf
10.25 0 0 10.25 45 599.5 Tm
<00240046004600480053005700480047001D>Tj
/TT0 1 Tf
10.5 0 0 10.5 94.5533 599.5 Tm
( 3/23/2018)Tj
/C2_0 1 Tf
10.25 0 0 10.25 45 587 Tm
<003500480059004C0048005A00480055001D0003>Tj
/C2_1 1 Tf
10.5 0 0 10.5 96.275 587 Tm
<00240047004400520045004C0003002E004400510058000300300027000F0003002D0052004B005100030033004C005B004F0048005C000300300027>Tj
/C2_0 1 Tf
10.25 0 0 10.25 45 574.75 Tm
<00260052005100C0004C0046005700560003005200490003004C0051005700480055004800560057001D>Tj
/C2_1 1 Tf
<00030031005200510048>Tj
/TT0 1 Tf
( )Tj
/C2_1 1 Tf
10 0 0 10 45 562.5 Tm
<0037004B004C00560003005A00520055004E0003004C00560003004F004C00460048005100560048004700030058005100470048005500030044000300260055004800440057004C00590048000300260052005000500052005100560003>Tj
0 -1.25 TD
<0024005700570055004C004500580057004C0052005100100036004B0044005500480024004F004C004E004800030017001100130003002C0051005700480055005100440057004C005200510044004F0003002F004C004600480051005600480011>Tj
ET
q
0 0 630 810 re
W n
BT
/T1_1 1 Tf
13 0 0 13 45 507 Tm
(R)Tj
9.1 0 0 9.1 53.6709 507 Tm
(EFE)Tj
/Span<>> BDC
(R)Tj
EMC
(ENCES)Tj
ET
Q
BT
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
10 0 0 10 45 482 Tm
( )Tj
EMC
[(1)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.099 Tw 1.8 0 Td
[(F)49.8(euchtbaum L, Car)-19.7(ter J)59.8(, Do)39.8(wra)34.9(y S, et al. Bir)-19.8(th pre)24.9(v)24.9(alence )]TJ
0.052 Tw 0 -1.2 TD
[(of disorders detectab)19.8(le through ne)24.9(wbor)-19.7(n screening b)24.9(y race/)]TJ
0 Tw T*
[(ethnicity)85(. Genet Med 2012;14:937\226945.)]TJ
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(2)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.1 Tw 1.8 0 Td
[(Lachenal F)129.8(, Nkana K, No)44.9(v)14.9(e-Josserand R, et al. Pre)24.9(v)24.9(alence )]TJ
0.163 Tw T*
(and clinical signi\037cance of auto-antibodies in adults with )Tj
0 Tw T*
[(c)14.9(ystic \037brosis. Eur Respir J 2009;34:1079\2261085. )]TJ
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(3)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0 Tw 1.8 0 Td
[(Lindber)17.9(g U)79.8(, Carlsson M, Hellmark )49.8(T)99.8(, et al. BPI-ANCA pro)]TJ
(-)Tj
0.169 Tw T*
[(vides )0.6(additional )0.5(clinical )0.6(infor)-19.8(mation )0.6(to )0.5(anti-Pseudomonas )]TJ
0.028 Tw T*
[(serolo)24.9(gy: results from a cohor)-19.7(t of 117 Sw)35(edish c)14.9(ystic \037bro)]TJ
0 Tw (-)Tj
T*
(sis patients. J Immunol Res 2015;934\226947.)Tj
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(4)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc -0.01 Tw 1.8 0 Td
[(Carlsson M, Eriksson L, Erw)25(ander I, et al. Pseudomonas-in)]TJ
0 Tw (-)Tj
0.117 Tw T*
[(duced lung damage in c)14.9(ystic \037brosis cor)-29.8(relates to bacteri)]TJ
0 Tw (-)Tj
0.106 Tw T*
[(cidal-per)-19.7(meability increasing protein \(BPI\)-autoantibodies. )]TJ
0 Tw T*
(Clin Exp Rheumatol 2003;32:95\226100. )Tj
/T1_0 1 Tf
-0.02 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(5)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0.01 Tc -0.09 Tw 1.8 0 Td
[(Cobano)24.9(glu )0.5(N)24.9(, Ozcelik U)79.9(, Cetin )0.5(I, )0.5(et )0.5(al. )55.4(Anti-neutrophil )0.5(c)14.9(yto)]TJ
0 Tc 0 Tw (-)Tj
0.01 Tc 0.013 Tw T*
[(plasmic antibodies \(ANCA\) in ser)-19.8(um and bronchoalv)14.9(eolar)10( )]TJ
0.141 Tw 28.2 39.616 Td
[(la)34.9(v)24.9(age \036uids of c)14.9(ystic \037brosis patients and patients with)10( )]TJ
-0.018 Tw T*
[(idiopathic bronchiectasis. )49.5(T)84.9(urk J P)39.8(ediatr 2010;52:343\226347.)]TJ
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(6)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc -0.003 Tw 1.8 0 Td
[(Cooper )50(T)99.8(, Sa)35(vige J)59.8(, Nassis L, et al. Clinical associations and )]TJ
0.31 Tw T*
[(characterization of antineutrophil c)14.9(ytoplasmic antibodies )]TJ
-0.031 Tw T*
[(directed ag)4.9(ainst bactericidal/per)-19.7(meability-increasing protein )]TJ
0 Tw T*
(and azurocidin. Rheumatol Int 2000;19:129\226136. )Tj
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(7)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.181 Tw 1.8 0 Td
[(Dorlochter L, Carlsson M, Olafsdottir E, et al. )55.1(Anti-neu)]TJ
0 Tw (-)Tj
0.104 Tw T*
[(trophil c)14.9(ytoplasmatic antibodies and lung disease in c)14.9(ystic )]TJ
0 Tw T*
[(\037brosis. J Cyst F)19.8(ibros 2004;3:179\226183.)]TJ
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(8)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc -0.031 Tw 1.8 0 Td
[(Dunn C, )29.4(W)79.9(almsle)14.9(y R, Dedrick R, et al. )54.6(Anti-neutrophil c)14.9(yto)]TJ
0 Tw (-)Tj
-0.143 Tw T*
[(plasmic autoantibodies \(ANCA\) to bactericidal/per)-19.7(meability-)]TJ
0 Tw ( )Tj
0.237 Tw T*
[(increasing )0.5(\(BPI\) )0.5(protein )0.5(reco)25(gnize )0.5(the carbo)19.9(xyl ter)-19.7(minal )]TJ
0 Tw T*
(domain. J Infect 1999;39:81\22687.)Tj
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.2 Td
( )Tj
EMC
[(9)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.163 Tw 1.8 0 Td
[(Rotschild M, Elias N)24.9(, Berk)9.8(o)39.8(witz D)59.8(, et al. )55.3(Autoantibodies )]TJ
0.302 Tw T*
[(ag)4.9(ainst bactericidal/per)-19.8(meability-increasing protein \(BPI-)]TJ
-0.008 Tw T*
[(ANCA\) in c)14.9(ystic \037brosis patients treated with azithrom)39.8(ycin. )]TJ
0 Tw T*
(Clin Exp Med 2005;5:80\22685.)Tj
/T1_0 1 Tf
-1.8 -1.2 Td
(10.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
0.134 Tw 0.58 0 Td
[(Schultz H. F)19.8(rom infection to autoimmunity: a ne)24.9(w model )]TJ
-0.02 Tw T*
[(for )0.5(induction of )55.4(ANCA )0.5(ag)4.9(ainst )0.5(the bactericidal/per)-19.7(meability )]TJ
0 Tw T*
[(increasing protein \(BPI\). )55(Autoimmun 2007;6:223\226227. )]TJ
/T1_0 1 Tf
-1.8 -1.2 Td
(11.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
0.079 Tw 0.58 0 Td
[(Schultz H, Cser)-19.7(nok E, Johnston )50(T)99.8(, et al. Use of nati)24.9(v)14.9(e and )]TJ
0.409 Tw T*
[(recombinant bactericidal/per)-19.7(meability-increasing proteins )]TJ
0.15 Tw T*
(\(bpi\) as antigens for detection of BPI-ANCA. J Immunol )Tj
0 Tw T*
(Methods 1997;205:127\226133. )Tj
/T1_0 1 Tf
-1.8 -1.2 Td
(12.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
0.139 Tw 0.58 0 Td
[(Sedi)24.9(v)24.9(a )54.8(A, Bar)-19.8(tunk)9.8(o)44.9(v)24.9(a J)59.9(, Bar)-19.8(toso)45(v)24.9(a J)59.9(, et al. )54.8(Antineutrophil )]TJ
0.057 Tw T*
[(c)14.9(ytoplasmic antibodies directed ag)4.9(ainst bactericidal/per)-19.7(me)]TJ
0 Tw (-)Tj
0.198 Tw T*
[(ability-increasing )0.6(protein )0.5(detected )0.5(in )0.5(children )0.5(with )0.5(c)14.9(ystic )]TJ
0.017 Tw T*
(\037brosis inhibit neutrophil-mediated killing of )Tj
/T1_3 1 Tf
0 Tw (Pseudomonas )Tj
T*
(aeruginosa)Tj
/T1_2 1 Tf
(. Microbes Infect. 2003;5:27\22630. )Tj
/T1_0 1 Tf
-1.8 -1.2 Td
(13.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
0.016 Tw 0.58 0 Td
[(W)79.8(ada )90.3(Y)128.9(, K)25(uroda )50.1(T)99.9(, Murasa)39.8(w)24.9(a )55.3(A, et al. )55.3(Anti-neutrophil c)15(yto)]TJ
0 Tw (-)Tj
0.376 Tw T*
[(plasmic autoantibodies ag)4.9(ainst bactericidal/per)-19.7(meability-)]TJ
0 Tw ( )Tj
0.073 Tw T*
[(increasing protein in patients with rheumatoid ar)-19.7(thritis and )]TJ
0.003 Tw T*
[(their cor)-29.8(relation with bronchial in)39.8(v)19.8(olv)14.9(ement. Mod Rheuma)]TJ
0 Tw (-)Tj
T*
(tol 2010;20:252\226256. )Tj
ET
endstream
endobj
23 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
BT
0 0 0 1 k
/GS0 gs
/T1_0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 8 0 0 8 281.0051 54.1778 Tm
(The Southwest Respiratory and Critical Care Chronicles 2018;6\(23\):48-5\
0)Tj
ET
endstream
endobj
33 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
0 0 0 1 K
0.5 w 4 M 0 j 0 J
/GS0 gs
q 1 0 0 1 45 68.8957 cm
0 0 m
540 0 l
S
Q
10 M
q 1 0 0 1 45 740.2762 cm
0 0 m
540 0 l
S
Q
BT
0 0 0 1 k
/C2_0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 8 0 0 8 45 751.5262 Tm
<002C005A0058004D004C00030048005700030044004F0011>Tj
/Span<>> BDC
<0003>Tj
EMC
36.6 0 Td
<0024005800570052004C0050005000580051004C0057005C0003002C005100030026005C00560057004C004600030029004C0045005500520056004C0056001D00030036004C004A0051004C00BF00460044005100460048000300440051004700030026004F004C0051004C00460044004F0003002C00500053004F004C004600440057004C005200510056>Tj
ET
endstream
endobj
35 0 obj
<>
endobj
36 0 obj
[38 0 R]
endobj
37 0 obj
<>stream
H\]k0l/1-s69v!b
yO$9aUj,|lhf]iYIB^qT/;ZYZwcP,pl9B |llU5[67c~h =%SԹ^ZB_ej!x!#GEi%V_)("7JV(|G٥߭ţ(ʕ:yJSrP
:rP:xJHfX%*% ${R2AG aeaA'N 6iy:p/))))))t7a*볹b7k];}v@ѥf4U_+ zƺ:
endstream
endobj
38 0 obj
<>
endobj
39 0 obj
<>
endobj
40 0 obj
<>
endobj
41 0 obj
<>stream
H
`0 :
endstream
endobj
42 0 obj
<>stream
HV{pT}眻dl ]. M&<\I6
(&.3)`L"N ȳ܅@jՖ¤Xedo s=> .<
?7\rNyN&W,hYEMum|&ߤڪP[tG2M]1z1}gi=4e6RF[.ϠZӄˡBbZSԁ/sчisv<(^.IMXMalj2<FD=9)[L:u=wb66XW(
X|ϺAE(t7pjˬ\Gxy>4W̔JS5V}C0BO)fDv&v[^D>_ιjDiIf|J-V[l#vyP~$/ɛX5kmXVzs٘gV`BcXxflNB>-|K=hTM^gzΊGDHlҐl{*T2u6h$9"*llq}!>vS2 r)F4*rDZZO/&2 {sޡ:}E83f/rD_L5bX/(⼸ .N&de,dI>)p>OJqUQV;>L}Un84GwN,uV;t>|y(qF^pw-Qq_K&=4MStF+sb0i#j@o
}opH(qj7mQ5bhTzEruVIq}vexj/d;
_#^纯C(phF|x:A,9ir2=.nMmі
: St'(K Պ4mF蚘)b%<}D^rA]e%^Ï>4$b<
-Obfy>E3=jd-{(Y؋X0ͲO>HKn;vWeDZ'N:m71:)gEkhJ|w)gȅ=o]c(q-koyʋ暌9t'f%giec菅!H|>߃Ǎ?zÆy`p9Ae`oFzZjJɽz&{tJs:4. !ou3+h,8ƍBwΤ2]%},Y#I_SXnz~(/bbHwF<IAo5ԆB>/J(0
rsIp1bL1#2bHG⺳WfQ7ӌBSfCҀ0)1`1ׄ1LDP3c:
Lǧ>H5-n
zU)Ce$/-4Sʇ,!ëtskin~+2"6bj;boT)oL0j\Mè10B}#Oo:Ӻrrs"lFz$v ݺ
TubPL܆Jwl>OgO2~UBx(UFeVr;ߦ6mpٍ/>J uP۰A9:w`5
Yd9
-bQô q=[|ˈti17c?|y2Smw8gٜp:Ճo3_O/mI}~]/at8ؑے]vN^d*r'Vt
H2ure3[1F!te b}ek>?ui{c]%3."wZ8=t|۶dI>[~mْ,[ "%`Ḅ LJ0II!-Ihh:pg
$͐Lڔ[`d:CfLfRqqHK:ޭnu;Ԯۇs3Ϯ҂TrGhnܾw #g#- -%
PJ\I$9p 1*6sG:JSd#BiihCjH#M錀 $bYq;m̵g݄''Pz1ԯ]>VfoY6,
m sRlrӬ-&0jga5ڵƚ3Bn
4i7"'L hRVI4ZY1$S$=$Bw8ɦ Exda{nW/țNQvL:V=I5ll1]'ʘ066hM
ұF
"*Q![zo~442Es_c